Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1953 1
1954 5
1955 3
1956 5
1958 2
1960 1
1961 2
1963 2
1964 1
1966 9
1967 1
1968 3
1969 3
1970 3
1972 2
1973 2
1974 2
1976 5
1977 7
1979 3
1980 1
1983 1
1984 4
1985 1
1986 1
1987 6
1988 4
1989 9
1990 6
1991 3
1992 6
1993 5
1994 6
1995 12
1996 8
1997 10
1998 18
1999 16
2000 18
2001 18
2002 20
2003 23
2004 33
2005 42
2006 52
2007 66
2008 64
2009 70
2010 105
2011 121
2012 119
2013 116
2014 117
2015 134
2016 155
2017 181
2018 218
2019 203
2020 235
2021 247
2022 249
2023 222
2024 233
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,867 results

Results by year

Filters applied: . Clear all
Page 1
Comparative review of imipenem/cilastatin versus meropenem.
Salmon-Rousseau A, Martins C, Blot M, Buisson M, Mahy S, Chavanet P, Piroth L. Salmon-Rousseau A, et al. Among authors: martins c. Med Mal Infect. 2020 Jun;50(4):316-322. doi: 10.1016/j.medmal.2020.01.001. Epub 2020 Feb 5. Med Mal Infect. 2020. PMID: 32035719 Review.
Author's Response.
Martins CC. Martins CC. J Am Dent Assoc. 2023 Jun;154(6):457. doi: 10.1016/j.adaj.2023.03.013. Epub 2023 Apr 21. J Am Dent Assoc. 2023. PMID: 37086255 No abstract available.
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment.
Hardaker EL, Sanseviero E, Karmokar A, Taylor D, Milo M, Michaloglou C, Hughes A, Mai M, King M, Solanki A, Magiera L, Miragaia R, Kar G, Standifer N, Surace M, Gill S, Peter A, Talbot S, Tohumeken S, Fryer H, Mostafa A, Mulgrew K, Lam C, Hoffmann S, Sutton D, Carnevalli L, Calero-Nieto FJ, Jones GN, Pierce AJ, Wilson Z, Campbell D, Nyoni L, Martins CP, Baker T, Serrano de Almeida G, Ramlaoui Z, Bidar A, Phillips B, Boland J, Iyer S, Barrett JC, Loembé AB, Fuchs SY, Duvvuri U, Lou PJ, Nance MA, Gomez Roca CA, Cadogan E, Critichlow SE, Fawell S, Cobbold M, Dean E, Valge-Archer V, Lau A, Gabrilovich DI, Barry ST. Hardaker EL, et al. Among authors: martins cp. Nat Commun. 2024 Feb 24;15(1):1700. doi: 10.1038/s41467-024-45996-4. Nat Commun. 2024. PMID: 38402224 Free PMC article.
Oral myiasis.
Martins CA, Freddo AL, Gomes FV, Santos ME, Araldi CA, Heitz C. Martins CA, et al. J Craniofac Surg. 2012 Mar;23(2):e69-71. doi: 10.1097/SCS.0b013e31824685f7. J Craniofac Surg. 2012. PMID: 22446462
The molecular pathogenesis of craniopharyngiomas.
Campanini ML, Almeida JP, Martins CS, de Castro M. Campanini ML, et al. Among authors: martins cs. Arch Endocrinol Metab. 2023 Mar 10;67(2):266-275. doi: 10.20945/2359-3997000000600. Epub 2023 Feb 7. Arch Endocrinol Metab. 2023. PMID: 36748936 Free PMC article. Review.
2,867 results